Financial Gravity Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-39
| Closed | -$16.3K | – | 2519 |
|
|
2024
Q1 | $16.3K | Buy |
39
+16
| +70% | +$6.71K | ﹤0.01% | 594 |
|
|
2023
Q4 | $9.51K | Buy |
23
+12
| +109% | +$4.96K | ﹤0.01% | 793 |
|
|
2023
Q3 | $4.38K | Sell |
11
-341
| -97% | -$136K | ﹤0.01% | 638 |
|
|
2023
Q2 | $4.57K | Buy |
352
+37
| +12% | +$481 | 0.01% | 496 |
|
|
2023
Q1 | $4.61K | Buy |
315
+26
| +9% | +$381 | 0.14% | 163 |
|
|
2022
Q4 | $4.03K | Sell |
289
-7,831
| -96% | -$109K | 0.02% | 434 |
|
|
2022
Q3 | $4.45K | Sell |
8,120
-340
| -4% | -$186 | 0.15% | 139 |
|
|
2022
Q2 | $4.6K | Buy |
8,460
+630
| +8% | +$342 | 0.14% | 148 |
|
|
2022
Q1 | $4.83K | Buy |
7,830
+4,970
| +174% | +$3.06K | 0.14% | 151 |
|
|
2021
Q4 | $1.62K | Buy |
2,860
+2,853
| +40,757% | +$1.62K | 0.04% | 348 |
|
|
2021
Q3 | $181K | Hold |
7
| – | – | 0.09% | 206 |
|
|
2021
Q2 | $202K | Sell |
7
-4
| -36% | -$115K | 0.07% | 187 |
|
|
2021
Q1 | $2.37K | Sell |
11
-33
| -75% | -$7.1K | 0.05% | 227 |
|
|
2020
Q4 | $10K | Buy |
+44
| New | +$10K | 0.01% | 181 |
|
|
2020
Q2 | – | Sell |
-297
| Closed | -$70.6K | – | 909 |
|
|
2020
Q1 | $70.6K | Sell |
297
-206
| -41% | -$48.9K | 0.22% | 50 |
|
|
2019
Q4 | $219K | Sell |
503
-251
| -33% | -$109K | 0.15% | 99 |
|
|
2019
Q3 | $128K | Sell |
754
-167
| -18% | -$28.4K | 0.11% | 175 |
|
|
2019
Q2 | $169K | Sell |
921
-197
| -18% | -$36.1K | 0.14% | 165 |
|
|
2019
Q1 | $208K | Buy |
+1,118
| New | +$208K | 0.17% | 131 |
|
|
2018
Q3 | $227K | Buy |
1,334
+214
| +19% | +$36.4K | 0.24% | 95 |
|
|
2018
Q2 | $196K | Sell |
1,120
-96
| -8% | -$16.8K | 0.18% | 117 |
|
|
2018
Q1 | $182K | Buy |
+1,216
| New | +$182K | 0.19% | 107 |
|